期刊文献+

心脏再同步治疗对慢性心力衰竭的临床疗效观察 被引量:1

Long-term effects of cardiac resynchronization therapy in patients with congestive heart failure
原文传递
导出
摘要 目的观察心脏再同步治疗(CRT)对慢性心力衰竭的长期临床疗效。方法24例接受CRT的慢性心力衰竭患者,心功能Ⅲ~Ⅳ级(NYHA分级),左心室射血分数(LVEF)≤0.35,左心室舒张末内径(LVEDD)/〉55mm,QRS时限≥120/TIS。植入前超声心动图及组织多普勒检查以评价心功能及心脏收缩不同步指标,并指导左心室电极导线的植入。植入后3、6个月及随后的每6个月进行随访,随访内容包括临床症状、心电图、LVEDD、LVEF及多普勒超声评价心脏收缩同步性指标。结果随访时间(12.0±4.6)个月,结果显示患者临床症状明显改善,QRS时限植入后较植入前缩短[(137.50±38.96)ms对(144.60±45.78)ms,P=0.67],但差异无统计学意义。植人后LVEDD较植入前明显缩小[(6.24±0.89)cm对(6.78±0.42)cm,P=0.03];LVEF则明显提高(0.36±0.09对0.31±0.03,P〈0.01),左心房内径(LAD)也较术前明显缩小[(4.22±8.43)cm对(5.32±7.63)cm,P=0.01]。心脏收缩不同步指标与植入前相比也明显改善。结论对慢性心力衰竭的患者,CRT治疗可改善左心室功能,逆转左心室重构。 Objective To observe the long-term effects of cardiac resynchronization therapy (CRT) in patients with congestive heart failure(CHF). Methods Twenty-four patients fulfilled the CRT indication with New York Heart Association(NYHA) Ⅲ -Ⅳ, QRS duration ≥ 120 ms, LVEF≤0. 35, LVEDD≥55 mm were studied by echocardiography before and after resynchronization. Intra-ventricular and inter-ventricular asynchrony were assessed by tissue Doppler imaging(TDI). Patients were followed up 3,6 monthes and every 6 monthes after operation. Results Patients were followed up for ( 12.0 ± 4. 6) months, with significant reduction of left ventricular end-diastolic (LVEDD) [ (6. 24 ±O. 89) cm vs (6. 78 ± O. 42) cm, P = 0. 03 ] and left atrail dimension (LAD) [ (4. 22± 8.43 ) cm vs ( 5.32± 7.63 )cm, P = 0. 01 1. The left vertricular ejection fraction (LVEF) was increased ( 0. 36 ± 0.09 vs 0. 31± 0. 03, P 〈 0. 01 ). The intra-ventrieular and inter-ventricular asynchrony indexes were significantly improved. Conclusion CRT improves the LV systolic function associated with the LV reverse remodeling.
出处 《中华心律失常学杂志》 2009年第1期13-15,共3页 Chinese Journal of Cardiac Arrhythmias
关键词 心脏再同步治疗 心力衰竭 组织多普勒 Cardiac resynchronization therapy Heart failure Tissue Doppler imaging
  • 相关文献

参考文献9

  • 1Cleland JG, Daubert JC, ErdmannE, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005, 352:1539-1549.
  • 2Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation, 2003,108:2596-2603.
  • 3Nelson GS, Berger RD, Feticd BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle branch block. Circulation, 2000,102:3053-3059.
  • 4Abraham WT, Fisher WG, Smith AL, et al. MIRACLE study group cardiac resynchronizatoin in chronic heart failure. N Engl J Med, 2002, 346 : 1845-1853.
  • 5Bristow MR, Saxon LA, Boehmer J, et al. Comparison of medical therapy, pacing, and defibrillation in heart failure. (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med, 2004, 350:2140-2150.
  • 6Hunt SA, Abraham WT, Chin WH, et al. ACC/AHA 2005 Guideline Update for the diagnosis and Management of Chronic Heart Failure in the Adult-Summary Article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 2005, 112 : 1825-1852.
  • 7Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatments of Chronic heart failure: executive summary ( update 2005 ) : the task force foe the diagnosis and treatment of chronic heart failure of the european society of caradiology, Eur Heart J, 2005, 26 : 1115-1140.
  • 8王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 9Leclercq C, Victor F, Alonso C, et al. Comparative effects of permanent biventficular pacing for refractory heart failure in patients with stable sinus rhythm or atrial fibrillation. Am J Cardiol, 2000, 85:1154.

二级参考文献93

共引文献90

同被引文献19

  • 1王方正,张澍,华伟,胡大一,陈新.全国心脏起搏器临床应用调查(2002至2005年)[J].中华心律失常学杂志,2006,10(6):475-478. 被引量:21
  • 2Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Ab- normalities:a report of the American College of Cardiology/Ameri- can Heart Association Task Force on Practice Guidelines. ( Writ- ing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol,2008,51 : e1-62.
  • 3Dickstein K,Vardas PE,Aurlcchio A, et al. 2010 focused update of ESC Guidelines on device therapy in heart failure : an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribu- tion of the Heart Failure Association and the European Heart Rhythm Association. Eur J Heart Fail,2010,12 : 1143-1153.
  • 4McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute mad chronic heart failure 2012. Eur J Heart Fail,2012,14 : 803- 869.
  • 5Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA expert con- sensus on the monitoring of Cardiovascular Implantable Electronic Devices (CIEDs) : Description of techniques, indications, person- nel, frequency and ethical considerations. Europace, 2008, 10: 707-725.
  • 6Haycs DL, Naccarelli GV, Fuman S, et al. North American Society to Pacing and Electrophysiology. NASPE training requirements for cardiae implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Eleetrophysiol,2003,26 : 1556-1562.
  • 7Naccarelli GV,Conti JB, DiMarco JP,et al. 2008 COCATS 3 Tack Force 6: training in specialized electrophysiology,cardiac pacing, and arrhythmia management. Heart Rhythm ,2008,5:332-337.
  • 8Schoenfeld MH, Reynolds DW. Sophisticated remote implantable cardioverter-defibrillator follow-up: a status report. Pacing Clin Electrophysiol, 2005,28 : 235 -240.
  • 9Joseph GK, Wilkoff BL, Dresing T, et al. Remote interrogation and monitoring of implantable cardioverter defibrillators. J Interv Card Electrophysiol,2004,11 : 161-166.
  • 10Varma N, Epstein AE, Irimpen A, et al. Efficacy and safety of au- tomatic remote monitoring for implantable cardioverter-defibrilla- tot follow-up: The Lumos-T Safely Reduces Routine Office De- vice Follow-up (TRUST) trial. Circulation,2010,122:325-332.

引证文献1

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部